CANCER RESEARCH CAREER ENHANCEMENT The UNC Lineberger Comprehensive Cancer Center (LCCC) has a long history of successful training programs and other mentoring, career enhancement and educational activities, across the continuum of career stages. These include: pre-college and undergraduate students, pre- and post-doctoral fellows, junior faculty and rising senior faculty, health care and biomedical research professionals and LCCC research staff and administrators. Since its inception, the Cancer Research Career Enhancement (CRCE) Core has focused on integrating these current UNC LCCC activities and strengths in cancer research career enhancement and addressing gaps in the training portfolio. Led by faculty and staff with extensive training, mentorship, research and leadership experience, the Core is well equipped to meet the evolving needs of a large, diverse and dynamic Cancer Center. The specific activities offered by the CRCE include: 1) Identifying, integrating, and organizing resources for cancer-related education, training, and career development; 2) Promoting cancer research education and training for our professional degree candidates and post-graduate trainees; 3) Providing training, development, and continuing education opportunities for faculty of all stages; and 4) Stimulating excitement and interest in cancer research through educational outreach to the broader non-cancer community. The CRCE promotes these initiatives through efforts such as: the LCCC-NC School of Math and Science pre-college cancer research program; LCCC undergraduate cancer research training including an NCI-funded partnership with a nearby Historically Black College or University (North Carolina Central University); engagement with the North Carolina Community College system for cancer education/training; multiple NCI T32 training programs for pre- and post-doctoral fellows; the Lineberger-Lauterborn Nursing Oncology Fellowship program; the Junior Faculty Career Development Group; and multiple meetings and events that add value to the LCCC by facilitating cross-disciplinary collaboration and innovation. These training opportunities have yielded impressive results such as 85% of previous trainees from our LCCC- North Carolina Central University PARTNERs program attending graduate or medical school. LCCC total direct costs funding from 67 training awards, including 11 NCI T32 awards, totals $10.7M. Over the next five years, the CRCE will improve or systematize ongoing activities by: broadening our partnership efforts with the LCCC COE; developing methods for collecting and analyzing outcomes from CRCE programs including longitudinal tracking of all trainees; expanding the NC Community College program; and designing new programs to serve a broader base of CRCE constituents. CRCE also strives to increase the diversity of students, trainees, and faculty at UNC and in the larger cancer research community.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016086-45
Application #
10089810
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-06-01
Project End
2025-11-30
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
45
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Song, Wantong; Shen, Limei; Wang, Ying et al. (2018) Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap. Nat Commun 9:2237
Kaur, Gurpreet; Guruprasad, Kunchur; Temple, Brenda R S et al. (2018) Structural complexity and functional diversity of plant NADPH oxidases. Amino Acids 50:79-94
McNeill, Robert S; Stroobant, Emily E; Smithberger, Erin et al. (2018) PIK3CA missense mutations promote glioblastoma pathogenesis, but do not enhance targeted PI3K inhibition. PLoS One 13:e0200014
Graham-Gurysh, Elizabeth; Moore, Kathryn M; Satterlee, Andrew B et al. (2018) Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection. Mol Pharm 15:1309-1318
Trout, Susan; Goldstein, Adam O; Marks, Lawrence et al. (2018) Treating Tobacco Use in Patients with Incurable Malignancies: Should We Even Start the Conversation? J Palliat Med 21:746-750
Lee, Clara Nan-Hi; Pignone, Michael Patrick; Deal, Allison M et al. (2018) Accuracy of Predictions of Patients With Breast Cancer of Future Well-being After Immediate Breast Reconstruction. JAMA Surg 153:e176112
Ricketts, Christopher J; De Cubas, Aguirre A; Fan, Huihui et al. (2018) The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep 23:313-326.e5
Golden, Shelley D; Kong, Amanda Y; Lee, Joseph G L et al. (2018) Disparities in cigarette tax exposure by race, ethnicity, poverty status and sexual orientation, 2006-2014, USA. Prev Med 108:137-144
Morgan, Jennifer C; Southwell, Brian G; Noar, Seth M et al. (2018) Frequency and Content of Conversations About Pictorial Warnings on Cigarette Packs. Nicotine Tob Res 20:882-887
Liu, Qi; Zhu, Hongda; Liu, Yun et al. (2018) BRAF peptide vaccine facilitates therapy of murine BRAF-mutant melanoma. Cancer Immunol Immunother 67:299-310

Showing the most recent 10 out of 1525 publications